Integrated approaches – Investing in efficient IBD treatment, enabling innovation in patient care delivery

EU must address barriers to continuous off-patent… 23 February 2021 EU Pharma strategy provides unique moment to establish a regulatory…
Scientific advice for continuous innovation in known… 5 May 2022 Open
European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
Generic & biosimilar medicines pivotal for… 28 November 2019 The European Commission has identified the use of generic and…